Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 4/20 | 0.61 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | OXTR | P30559 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7340853 | 0.88 | GAA (0.54) | AVPR2AVPR1AGAARAB9ASMN1; SMN2 | |
| SCHEMBL8560800 | 0.86 | AVPR2 (0.79) | AVPR2AVPR1AOXTR | |
| SCHEMBL8558993 | 0.84 | AVPR2 (0.65) | AVPR2AVPR1A | |
| SCHEMBL8556275 | 0.83 | AVPR2 (0.69) | AVPR2AVPR1AOXTR | |
| SCHEMBL7333136 | 0.83 | AVPR2 (0.68) | AVPR2AVPR1A | |
| SCHEMBL8560873 | 0.82 | ACHE (0.60) | AVPR2AVPR1ARAB9A | |
| SCHEMBL7369344 | 0.82 | AVPR2 (0.70) | AVPR2AVPR1AOXTR | |
| SCHEMBL8564269 | 0.82 | AVPR2 (0.61) | AVPR2AVPR1AOXTR | |
| SCHEMBL8562029 | 0.81 | AVPR2 (0.58) | AVPR2AVPR1A | |
| SCHEMBL8561438 | 0.81 | AVPR2 (0.59) | AVPR2AVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0640592-B1 | N-acylated tricyclic azaheterorings useful as vasopressin antagonists | AMERICAN CYANAMID CO (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0640592-A1 | N-acylated tricyclic azaheterorings useful as vasopressin antagonists | AMERICAN CYANAMID COMPANY (US) | 1995-03-01 | — | — | EP | disclosed |